go back

Oklahoma rates for HCPCS Q2053

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $41,687 · 10th–90th $22,909–$524,8070%5%10%10th90th$41,687Professionalmedian $489,779 · 10th–90th $489,779–$588,8440%50%90th$489,779$20.0K$50.0K$100.0K$200.0K$500.0K$1.0M$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$489,778.82 / $524,807.46 / $891,250.94
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $588,843.66
BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$22,387.21 / $34,673.69 / $57,543.99
Cigna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$537,031.80 / $537,031.80 / $537,031.80
Medica
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$478,630.09 / $645,654.23 / $954,992.59
Medica
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$1,000,000.00 / $1,000,000.00 / $1,000,000.00
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $812,830.52
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$436,515.83 / $512,861.38 / $549,540.87